Zinaida Yu Mutovina (Z Y Mutovina, Z I Mutovina, Z Yu Mutovina)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Peritoneal Dialysis

Coronavirus Disease

Respiratory Syndrome Coronavirus

Prognostic Factors

Top Venues

Terapevticheskii arkhiv

Pathogens & immunity

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

This page only lists publications with an associated author ORCID identifier.

Publications

Sergey N Avdeev, Vladimir P Chulanov, Ekaterina Alexeeva, O A Aleshina, A V Bereznikov, O N Kotenko, Alexander M Lila, Zinaida Yu Mutovina, Elena N Parovichnikova, Darya S Fomina, N F Frolova, A O Shevchenko
[The burden of COVID-19 in a heterogeneous population of immunocompromised patients - realities of the postpandemic]. Terapevticheskii arkhiv 95 (8) (2023)
M S Lebedkina, Darya S Fomina, Zinaida Yu Mutovina, U A Mаrkina, P O Bogomolov, Vladimir P Chulanov, Mar'yana A Lysenko, Ekaterina Alexeeva
[Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study]. Terapevticheskii arkhiv 95 (6) (2023)
Sergey N Avdeev, Vladimir P Chulanov, Ekaterina Alexeeva, O A Aleshina, A V Bereznikov, O N Kotenko, Alexander M Lila, Zinaida Yu Mutovina, Elena N Parovichnikova, Darya S Fomina, N F Frolova, A O Shevchenko
[The burden of COVID-19 in a heterogeneous population of immunocompromised patients - realities of the postpandemic]. Terapevticheskii arkhiv 95 (8) (2023)
M S Lebedkina, Darya S Fomina, Zinaida Yu Mutovina, U A Mаrkina, P O Bogomolov, Vladimir P Chulanov, Mar'yana A Lysenko, Ekaterina Alexeeva
[Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study]. Terapevticheskii arkhiv 95 (6) (2023)
Vladimir P Chulanov, Bulat A Bakirov, N N Vezikova, V N Gorodin, M V Zhuravleva, A I Zagrebneva, I G Ivanov, Nikita V Lomakin, Galina V Lukina, D L Moysova, Zinaida Yu Mutovina
[Experience of anticipatory therapy with IL-6 receptor inhibitors and perspectives for its use in the evolution of COVID-19]. Terapevticheskii arkhiv 94 (8) (2022)
U A Mаrkina, Darya S Fomina, M S Lebedkina, Tat'yana S Kruglova, Anton A Chernov, A I Zagrebneva, Zinaida Yu Mutovina, Alexander V Karaulov, Ekaterina Alexeeva, Mar'yana A Lysenko
[Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit]. Terapevticheskii arkhiv 94 (5) (2022)
M V Putilina, Zinaida Yu Mutovina, Olga Kurushina, D M Khalilova, E N Saverskaya, S B Stepanova, M A Khoreva, A S Starikov
[Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (1) (2022)
Tat'yana S Kruglova, Darya S Fomina, Nataliya G Poteshkina, N F Frolova, Irina P Beloglazova, Zinaida Yu Mutovina, Inna V Samsonova, E A Kovalevskaja, A I Zagrebneva, S A Serdotetckova, Anton A Chernov, Mar'yana A Lysenko
[Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19]. Terapevticheskii arkhiv 93 (11) (2021)
Darya S Fomina, Mar'yana A Lysenko, Irina P Beloglazova, Zinaida Yu Mutovina, Nataliya G Poteshkina, Inna V Samsonova, Tat'yana S Kruglova, Anton A Chernov, Alexander V Karaulov
Temporal Clinical and Laboratory Response to Interleukin-6 Receptor Blockade With Tocilizumab in 89 Hospitalized Patients With COVID-19 Pneumonia. Pathogens & immunity 5 (1) (2020)